| 000 | 01846 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250517120856.0 | ||
| 264 | 0 | _c20171120 | |
| 008 | 201711s 0 0 eng d | ||
| 022 | _a2044-5385 | ||
| 024 | 7 |
_a10.1038/bcj.2016.83 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLim, K-H | |
| 245 | 0 | 0 |
_aExpression of CALR mutants causes mpl-dependent thrombocytosis in zebrafish. _h[electronic resource] |
| 260 |
_bBlood cancer journal _c10 2016 |
||
| 300 |
_ae481 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalreticulin _xgenetics |
| 650 | 0 | 4 |
_aCarcinogenesis _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHematopoiesis |
| 650 | 0 | 4 |
_aHematopoietic Stem Cells _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJanus Kinase 2 _xgenetics |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aMyeloproliferative Disorders _xdrug therapy |
| 650 | 0 | 4 | _aNitriles |
| 650 | 0 | 4 |
_aPrimary Myelofibrosis _xdrug therapy |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacology |
| 650 | 0 | 4 | _aPyrimidines |
| 650 | 0 | 4 |
_aPyrrolidines _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Thrombopoietin _xgenetics |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 650 | 0 | 4 |
_aThrombocythemia, Essential _xdrug therapy |
| 650 | 0 | 4 |
_aThrombocytosis _xdrug therapy |
| 650 | 0 | 4 | _aZebrafish |
| 700 | 1 | _aChang, Y-C | |
| 700 | 1 | _aChiang, Y-H | |
| 700 | 1 | _aLin, H-C | |
| 700 | 1 | _aChang, C-Y | |
| 700 | 1 | _aLin, C-S | |
| 700 | 1 | _aHuang, L | |
| 700 | 1 | _aWang, W-T | |
| 700 | 1 | _aGon-Shen Chen, C | |
| 700 | 1 | _aChou, W-C | |
| 700 | 1 | _aKuo, Y-Y | |
| 773 | 0 |
_tBlood cancer journal _gvol. 6 _gno. 10 _gp. e481 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bcj.2016.83 _zAvailable from publisher's website |
| 999 |
_c26495391 _d26495391 |
||